HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas D Hartkopf Selected Research

Paclitaxel (Taxol)

1/2023Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
1/2020EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas D Hartkopf Research Topics

Disease

73Breast Neoplasms (Breast Cancer)
04/2024 - 03/2011
35Neoplasms (Cancer)
04/2024 - 02/2011
8Triple Negative Breast Neoplasms
08/2023 - 10/2019
5Disease Progression
01/2023 - 04/2020
5Neoplasm Metastasis (Metastasis)
01/2021 - 12/2012
4Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 03/2018
4Residual Neoplasm
01/2023 - 01/2018
4Circulating Neoplastic Cells
07/2020 - 03/2011
2Brain Neoplasms (Brain Tumor)
06/2022 - 12/2018
2Nausea
01/2021 - 03/2018
2Vomiting
01/2021 - 03/2018
2Ovarian Epithelial Carcinoma
01/2020 - 01/2018
1Chromosome Aberrations (Chromosome Abnormalities)
01/2023
1Pathologic Complete Response
05/2021
1Fatigue
01/2021
1Exanthema (Rash)
01/2021
1Abdominal Pain (Pain, Abdominal)
01/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020
1Pain (Aches)
10/2019
1Musculoskeletal Pain
10/2019
1Arthralgia (Joint Pain)
10/2019
1Carcinoma (Carcinomatosis)
10/2018
1Alopecia (Baldness)
03/2018

Drug/Important Bio-Agent (IBA)

19Hormones (Hormone)IBA
06/2023 - 02/2018
13Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2018
5LigandsIBA
04/2024 - 12/2016
5Immune Checkpoint InhibitorsIBA
06/2022 - 12/2016
5Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2022 - 03/2018
5pertuzumabIBA
06/2021 - 01/2019
4Phenobarbital (Luminal)FDA Link
01/2024 - 01/2020
3Proteins (Proteins, Gene)FDA Link
08/2023 - 10/2018
3abemaciclibIBA
06/2023 - 03/2022
3sacituzumab govitecanIBA
03/2023 - 04/2021
3pembrolizumabIBA
03/2023 - 09/2022
3Immunoconjugates (Immunoconjugate)IBA
03/2023 - 04/2021
3human ERBB2 proteinIBA
01/2021 - 12/2018
3Estrogen ReceptorsIBA
08/2020 - 11/2014
3Progesterone Receptors (Progesterone Receptor)IBA
08/2020 - 11/2014
3TabletsIBA
01/2019 - 01/2017
2olaparibIBA
06/2023 - 03/2023
2atezolizumabIBA
03/2023 - 12/2019
2AntibodiesIBA
01/2023 - 12/2016
2Carboplatin (JM8)FDA LinkGeneric
01/2023 - 01/2020
2Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2021
2trastuzumab deruxtecanIBA
09/2022 - 06/2022
2AlpelisibIBA
06/2022 - 04/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
2Immune Checkpoint ProteinsIBA
01/2022 - 09/2021
2neratinibIBA
06/2021 - 01/2021
2Trastuzumab (Herceptin)FDA Link
01/2021 - 01/2019
2Ado-Trastuzumab EmtansineIBA
10/2020 - 10/2019
2ProgesteroneFDA LinkGeneric
08/2020 - 12/2016
2Estrogens (Estrogen)FDA Link
08/2020 - 01/2020
1micaIBA
04/2024
1Glucose (Dextrose)FDA LinkGeneric
01/2024
1AntigensIBA
12/2023
1Neoplasm Antigens (Tumor Antigens)IBA
08/2023
1Local AnestheticsIBA
03/2023
1Epithelial Cell Adhesion MoleculeIBA
01/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1130-nm albumin-bound paclitaxelIBA
01/2023
1Peptides (Polypeptides)IBA
11/2022
1VaccinesIBA
11/2022
1Protein Subunit VaccinesIBA
11/2022
1Circulating MicroRNAIBA
08/2022
1tucatinibIBA
06/2022
1giredestrantIBA
02/2022
1talazoparibIBA
02/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Metalloproteases (Metalloproteinases)IBA
06/2021
1DisintegrinsIBA
06/2021
1Capecitabine (Xeloda)FDA Link
06/2021
1Cyclin-Dependent Kinase 4IBA
05/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1seribantumabIBA
11/2020
1histidine-rich proteinsIBA
11/2020
1Indicators and Reagents (Reagents)IBA
07/2020
1TransferasesIBA
01/2020
1Histones (Histone)IBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
01/2020
1Aromatase InhibitorsIBA
10/2019
1Letrozole (Femara)FDA LinkGeneric
10/2019
1Keratins (Keratin)IBA
06/2018

Therapy/Procedure

50Therapeutics
09/2023 - 03/2011
11Drug Therapy (Chemotherapy)
08/2023 - 03/2011
6Neoadjuvant Therapy
03/2023 - 01/2018
4Immunotherapy
12/2023 - 10/2019
4Oncolytic Virotherapy
01/2022 - 02/2011
2Palliative Care (Palliative Therapy)
01/2023 - 01/2017
2Adjuvant Chemotherapy
10/2022 - 02/2016
2Precision Medicine
11/2018 - 11/2018
1Cytoreduction Surgical Procedures
01/2023
1Duration of Therapy
01/2023
1Secondary Prevention
04/2020
1Ligation
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
12/2019
1Segmental Mastectomy (Lumpectomy)
06/2019